Hsiao-Chun Wang

Bioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor.

J. Chern, Hsiang-Wen Tseng, Chih-Peng Liu, 2014, European journal of medicinal chemistry.

Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia.

J. Chern, Li-Jiuan Shen, Hsiang-Wen Tseng, 2014, European journal of medicinal chemistry.

Synthesis and structure-activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors.

J. Chern, Ling-mei Wang, Chiung-Hua Huang, 2010, Bioorganic & medicinal chemistry.

Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy

Ching Li, H. Tien, W. Chou, 2023, Journal of Hematopathology.

Developing a Parametric Carbon Footprinting Tool: A Case Study of Wafer Fabrication in the Semiconductor Industry

Ching-Yao Huang, Allen H. Hu, Jessica Yin, 2013 .